Articles related to RISK ASSESSMENT

The recent trial assessing CSL112’s role in enhancing cholesterol efflux capacity showed no significant reduction in cardiovascular events over one year among patients post-acute myocardial infarction, maintaining a safety profile consistent with placebo.

Recent systematic reviews suggest a subtle increase in NMOSD and MS risks post-COVID-19 vaccination, primarily affecting genetically susceptible individuals.

In the realm of assessing body weight and its health implications, BMI alone is insufficient. Delve into how additional metrics like WHR and WtHR enrich our understanding of patient health, guiding more informed clinical decisions.

The CXR CVD-Risk model stands at the forefront of integrating deep learning with radiography, offering a novel lens through which physicians can assess cardiovascular risk, especially in scenarios where conventional risk factors are not discernible.

MySTIRisk’s AI-driven analysis offers a nuanced approach to identifying patients at heightened risk for STIs, providing a crucial tool in optimizing healthcare strategies and interventions in sexual health clinics.